Clinical Trials in Salt Lake City

Showing 3121-3140 of 14,325 trials

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis

NCT04697056

Efficacy and Safety of imsidolimab in Participants with Ichthyosis

Vanda Pharmaceuticals5 participantsStarted Jan 2021

Palo Alto, California, United States • New Haven, Connecticut, United States • Miami, Florida, United States +4 more locations

RECRUITINGNA< 1 mile

The e-SINCERE Study

NCT07174466

The e-SINCERE study will evaluate whether providing stable cell phones and digital navigation assistance helps patients overcome ICT barriers and connect more successfully with community services. The study will begin with patients in the UHealth ED, with additional sites added in the future, and will involve working with community service providers and policy leaders to refine and implement the intervention. Findings from this study may guide the development of future programs and policies to improve access to services for patients facing economic and technological barriers.

Social Determinants of Health (SDOH)Digital Health LiteracyHealth Services Utilization

Andrea Wallace600 participantsStarted Aug 2025

Salt Lake City, Utah, United States

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis

The e-SINCERE Study

Find Trials by Condition in Salt Lake City

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

Study of Anti-Malarials in Incomplete Lupus Erythematosus

NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function

Veterans Response to Dosage in Chiropractic Therapy

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Promising ROd-cone DYstrophy Gene therapY

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer